Origins of the Human Genome Project

Dr. Cook-Deegan recounts some of the scientific and political history leading to controversy about the proper mix of private and public roles in pursuing genome research and bringing its fruits to bear, e.g., in preventing and curing disease

Patenting Nature: What Ruling in Myriad Case Means for Biotechnology and DNA Diagnostics

Editorial in 'The Cancer Letter', written by Professor Robert Cook-Deegan. This article was included in background materials provided at the September, 2011 Congressional briefing

Amici Brief of Certain Academics in Law, Medicine, Health Policy, and Clinical Genetics in Support of Petitioners

Brief of Amici Curiae ("friend of the court") submitted by certain academics in law, medicine, health policy, and clinical genetics in support of petitioners on petition for a Writ of Certiorari (No. 11-725

"The Myriad Genetics/Breast Cancer Gene Case: Can Human Genes be Patented?": Professor Robert Cook-Deegan's slides from CPG Congressional Issue Briefing

Professor Robert Cook-Deegan's presentation slides from the September 15, 2011 Congressional briefin

Issue Brief for Congressional Staff, entitled "Gene Patents: What do they do? What policy options have been proposed? What are the implications of the Myriad ruling?

Issue brief for congressional staff prepared by Robert Cook-Deegan to educate policymakers, advocacy groups, and other stakeholders about the Myriad case

Declaration of Robert M. Cook-Deegan, MD, Director of the Center for Genome Ethics, Law, and Policy of Duke's Institute for Genome Sciences and Policy

Declaration of Robert M. Cook-Deegan for the United States District Court Southern District of New Yor

Correspondence between Robert Cook-Deegan and Michael Waterman

Three letters written between Robert Cook-Deegan and Michael Waterman on the subject of DNA sequencing databases and the other BLAST historical documents provided here. (.pdf, 3 documents, 5 pages total)

Letter from Robert Cook-Deegan, M.D. and Alessandra Colaianni, B.A.

A 2008 attempt to obtain year-by-year licensing and revenue data from Columbia University. Previous attempts to obtain such data through the NIH Freedom of Information Act were unsuccessful

Center for Public Genomics List of Challenged Claims in Association for Molecular Pathology et al. v. United States Patent and Trademark Office et al.

List of challenged claims in the case, compiled and written by researchers at Duke University's Center for Public Genomic